Opportunities for electroceuticals in epilepsy

Omid Kavehei, Tara Julia Hamilton, Nhan Duy Truong, Armin Nikpour

Research output: Contribution to journalComment/opinionpeer-review

4 Citations (Scopus)


Epilepsy is a neurological disorder that affects ∼1% of the world population. Nearly 30% of epilepsy patients suffer from pharmacoresistant epilepsy that cannot be treated with antiepileptic drugs. Depending on seizure type, a diverse range of therapies are available, including surgery, vagus nerve stimulation, and deep brain stimulation. We review the sensing and stimulation technologies most used in neurological disorders, and provide a vision of minimally invasive electroceuticals to enable accurate forecasting of epileptic seizures and therapy. The use of such systems could potentially help patients to prevent injuries and, in combination with an intervention mechanism, could provide a method of suppressing seizures in epileptic patients.

Original languageEnglish
Pages (from-to)735-746
Number of pages12
JournalTrends in Pharmacological Sciences
Issue number10
Publication statusPublished - Oct 2019


Dive into the research topics of 'Opportunities for electroceuticals in epilepsy'. Together they form a unique fingerprint.

Cite this